These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 22465097)
1. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells. Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death. Nilsson EM; Brokken LJ; Härkönen PL Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of gene expression profiles in gastric cancer cell cycle]. Lan B; Liu BY; Cheng XH; Zhang J; Wang KK; Zhu ZG Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):568-71. PubMed ID: 17236548 [TBL] [Abstract][Full Text] [Related]
4. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation. Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. Balasenthil S; Barnes CJ; Rayala SK; Kumar R FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330 [TBL] [Abstract][Full Text] [Related]
6. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849 [TBL] [Abstract][Full Text] [Related]
7. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression. Perera CN; Chin HG; Duru N; Camarillo IG J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880 [TBL] [Abstract][Full Text] [Related]
8. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer. Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685 [TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919 [TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453 [TBL] [Abstract][Full Text] [Related]
12. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691 [TBL] [Abstract][Full Text] [Related]
13. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Chen C; Chang YC; Liu CL; Chang KJ; Guo IC Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079 [TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2. Paruthiyil S; Cvoro A; Tagliaferri M; Cohen I; Shtivelman E; Leitman DC Breast Cancer Res Treat; 2011 Oct; 129(3):777-84. PubMed ID: 21120602 [TBL] [Abstract][Full Text] [Related]
16. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553 [TBL] [Abstract][Full Text] [Related]
17. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Cui XS; Donehower LA Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550 [TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of p27(Kip1) in human breast cancers. Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577 [TBL] [Abstract][Full Text] [Related]
19. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. Lim D; Jocelyn KM; Yip GW; Bay BH Cancer Lett; 2009 Apr; 276(1):109-17. PubMed ID: 19062161 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]